Actively Recruiting
Epidural Electrical Stimulation in Spinal Cord Injury
Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2026-04-24
10
Participants Needed
1
Research Sites
95 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to evaluate the safety and effectiveness of Epidural Electrical Stimulation (EES) in motor and sensory function Reconstruction in chronic spinal cord injury (SCI) patients classified as ASIA B-D. The main questions it aims to answer are: Does EES treatment significantly improve motor and sensory function in patients with SCI compared to baseline? Is EES a safe intervention for this patient population? Researchers will compare participants' motor function, sensory function, and quality of life assessments before EES implantation, immediately after activation of the device, and at 1, 3, and 6 months post-implantation to evaluate the longitudinal effects of EES. Participants will: Undergo surgical implantation of an EES device in the epidural space. Have the EES device activated and receive personalized stimulation parameter adjustments during follow-up visits. Complete regular motor and sensory function assessments using standardized protocols. Participate in structured rehabilitation training sessions while using the EES device. Report any adverse events and complete quality of life questionnaires at specified follow-up intervals.
CONDITIONS
Official Title
Epidural Electrical Stimulation in Spinal Cord Injury
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Spinal Cord Injury classified as ASIA B, C, or D
- Injury level above the T10 vertebra
- Injury duration between 8 and 36 months
- WISCI II score less than 13
- No significant motor improvement after rehabilitation in the past 2 months
- Expected survival of 12 months or longer
- Voluntary participation with signed consent and ability to comply with rehabilitation and follow-up
You will not qualify if you...
- Other severe organic neurological diseases or mental illnesses besides anxiety or depression
- Bleeding or coagulation problems (prothrombin time 18 seconds or longer)
- History of alcohol or drug abuse or dependence
- Mental retardation, cognitive dysfunction, or personality disorders
- History of electroconvulsive therapy or need for continuous electrotherapy
- Implanted cardiac pacemaker, cardioverter, or defibrillator
- Expected survival less than 1 year
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China, 310009
Actively Recruiting
Research Team
J
Junming Zhu, Chief Physician
CONTACT
Z
Zhoule Zhu, Attending Physician
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here